Considering Stigma in the Provision of HIV Pre-Exposure Prophylaxis: Reflections from Current Prescribers
- PMID: 30715918
- PMCID: PMC6386080
- DOI: 10.1089/apc.2018.0166
Considering Stigma in the Provision of HIV Pre-Exposure Prophylaxis: Reflections from Current Prescribers
Abstract
Efforts to identify and address social inequities in HIV pre-exposure prophylaxis (PrEP) access are urgently needed. We investigated early-adopting PrEP prescribers' beliefs about how stigma contributes to PrEP access disparities in health care and explored potential intervention strategies within the context of PrEP service delivery. US-based PrEP prescribers were recruited through professional networks and participant referrals. Qualitative interviews were conducted, transcribed, and thematically analyzed. Participants (n = 18) were primarily male (72%); white (39%) or Asian (33%); and heterosexual (56%). Most practiced in the Northeastern (67%) or Southern (22%) United States; were physicians (94%); and specialized in HIV/infectious disease (89%). Participants described multiple forms of structural and interpersonal stigma impeding PrEP access. The requirement that PrEP be prescribed was a perceived deterrent for populations with medical mistrust and/or low health literacy. Practice norms such as discussing PrEP only in response to patient requests were seen as favoring more privileged groups. When probed about personally held biases, age-related stereotypes were the most readily acknowledged, including assumptions about older adults being sexually inactive and uncomfortable discussing sex. Participants criticized providers who chose not to prescribe PrEP within their clinical practice, particularly those whose decision reflected personal values related to condomless sex or discomfort communicating about sex with their patients. Suggested solutions included standardizing PrEP service delivery across patients and increasing cultural competence training. These early insights from a select sample of early-adopting providers illuminate mechanisms through which stigma could compromise PrEP access for key populations and corresponding points of intervention within the health care system.
Keywords: HIV; clinical decision making; health care disparities; patient care; pre-exposure prophylaxis; prejudice.
Conflict of interest statement
The authors disclose the following potential conflicts of interest: S.K.C., D.S.K., and K.H.M. have received compensation for their efforts in developing and/or delivering medical education related to PrEP. D.S.K. and K.H.M. have conducted research with unrestricted project support from Gilead Sciences, and K.H.M. has conducted research with unrestricted project support from Merck and ViiV Healthcare.
References
-
- Riddell J, 4th, Amico KR, Mayer KH. HIV preexposure prophylaxis: A review. JAMA 2018;319:1261–1268 - PubMed
-
- Bush S, Magnuson D, Rawlings MK, et al. . Racial Characteristics of FTC/TDF for Preexposure Prophylaxis (PrEP) Users in the US, Abstract 2651 Boston, MA: ASM Microbe, 2016
-
- Smith DK, Van Handel M, Grey JA. By race/ethnicity, Blacks have highest number needing PrEP in the United States. In: Conference on Retroviruses and Opportunistic Infections (CROI 2018), Abstract 86, Boston, MA, 2018
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous